Skip to main content
. Author manuscript; available in PMC: 2009 Jun 1.
Published in final edited form as: Antiviral Res. 2008 Feb 4;78(3):223–229. doi: 10.1016/j.antiviral.2008.01.005

Fig. 2.

Fig. 2

Comparison of once daily or twice daily every 12 h 30-min MegaRibavirin (100 mg/mL; Rib) aerosol treatments on survival and lung virus titers of influenza A/HK/8/68 (H3N2) virus-infected mice. A. Effect on survival. *, P value ≤ 0.05 for comparing the survival curves in each group to the untreated group in each of the experiments using ANOVA with Bonferroni multiple comparisons tests, two-tailed. B. Effect on lung virus titers. *, P value < 0.05 for comparing the lung virus titers (mean ± standard deviation) in each group to the untreated group using the Student's t-Test, two-tailed on log10/lung transformed data.